Introduction This study presents an observational analysis of acute poisoning cases admitted to Dhaka Medical College Hospital, Bangladesh, over a two-month period, highlighting key demographic, etiological, clinical, and outcome-based trends.

Results A total of 611 cases were reviewed, with a predominant incidence among young adults aged 20-40 years. The highest fatality rate occurred in the 16-25-year-old cohort, with a secondary fatality peak noted among individuals aged 66-70, indicating varying vulnerability across age groups. Pesticide-related poisonings were common, with nearly equal distributions between organophosphorus compounds (51%) and non-organophosphorus compounds (49%). Commuter poisoning (31.2%) was notably the leading type of non-pesticide poisoning, primarily associated with criminal activities. Suicidal poisoning accounted for most cases at 57.4%, often linked to family disharmony as a frequent underlying factor. Additionally, snake bites (7.5%) emerged as a notable public health concern, especially in rural areas.

Fatalities were highest among those who ingested kerosene (20%), despite its low incidence. Logistic regression analysis identified key predictors of mortality, including severely low Glasgow Coma Scale scores (GCS<9; OR=80.59, p<0.001), hypotension, tachycardia, and pupillary abnormalities. Non-organophosphorus poisonings displayed increased severity in terms of neurological impairment and hypotension compared to organophosphorus poisonings, which mainly resulted in pupillary constriction.

Demographic analysis revealed a higher mortality risk among females, rural residents, and individuals with lower educational attainment, although the statistical significance was limited.

Conclusion This study identifies important gaps in managing and preventing acute poisoning in Bangladesh. It calls for structured clinical protocols, better training for healthcare providers, and targeted community interventions. Improving public awareness and timely medical responses is essential to reduce poisoning-related morbidity and mortality.

The authors have declared no competing interest.

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical approval was obtained from the Ethical Review Committee of Dhaka Medical College Hospital, ensuring compliance with ethical standards in medical research.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data are available in the manuscript and supplementary data